Abstract

—In the Board of Trustees Report entitled "Requirements or Incentives by Government for the Use of Long-Acting Contraceptives," published in the April 1,1992, issue ofTHE JOURNAL(1992;267:1818-1821), on page 1818 in the fourth paragraph, the third sentence should be two sentences and read as follows: "Nevertheless, because of the potential risks of supplemental hormonal therapy Norplant is contraindicated for patients with thrombotic disease, acute liver dysfunction, or breast cancer [not "diabetes, hypertension, cardiovascular disease, thrombotic disease, acute liver dysfunction, or breast cancer"]. Patients with diabetes, hypertension, or cardiovascular disease should be monitored for adverse effects."

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call